Kenneth C Anderson Selected Research

B-Cell Maturation Antigen

3/2024	Differentiation of BCMA-specific induced pluripotent stem cells into rejuvenated CD8αβ+ T cells targeting multiple myeloma.
12/2021	Promising Antigens for the New Frontier of Targeted Immunotherapy in Multiple Myeloma.
1/2020	BCMA peptide-engineered nanoparticles enhance induction and function of antigen-specific CD8+ cytotoxic T lymphocytes against multiple myeloma: clinical applications.
11/2019	B cell maturation antigen (BCMA)-based immunotherapy for multiple myeloma.
1/2019	Selective targeting of multiple myeloma by B cell maturation antigen (BCMA)-specific central memory CD8+ cytotoxic T lymphocytes: immunotherapeutic application in vaccination and adoptive immunotherapy.
1/2018	Targeting B Cell Maturation Antigen (BCMA) in Multiple Myeloma: Potential Uses of BCMA-Based Immunotherapy.
1/2016	APRIL and BCMA promote human multiple myeloma growth and immunosuppression in the bone marrow microenvironment.
1/2015	Targeting B-cell maturation antigen in multiple myeloma.
5/2014	Novel anti-B-cell maturation antigen antibody-drug conjugate (GSK2857916) selectively induces killing of multiple myeloma.
7/2006	Role of B-cell-activating factor in adhesion and growth of human multiple myeloma cells in the bone marrow microenvironment.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Kenneth C Anderson Research Topics

Disease

535	Multiple Myeloma 05/2024 - 01/2002
264	Neoplasms (Cancer) 04/2024 - 01/2002
34	Waldenstrom Macroglobulinemia (Macroglobulinemia) 01/2023 - 04/2003
32	Hematologic Neoplasms (Hematological Malignancy) 11/2023 - 04/2002
18	Disease Progression 01/2022 - 06/2005
17	Thrombocytopenia (Thrombopenia) 01/2024 - 05/2002
16	Lymphoma (Lymphomas) 01/2022 - 04/2003
11	Neutropenia 01/2022 - 12/2004
10	Anemia 01/2023 - 01/2009
10	Plasmacytoma 01/2017 - 09/2002
10	Peripheral Nervous System Diseases (PNS Diseases) 12/2015 - 07/2006
9	Residual Neoplasm 01/2024 - 11/2016
8	Fatigue 01/2022 - 07/2006
8	Leukemia 10/2019 - 04/2002
8	Bone Diseases (Bone Disease) 01/2019 - 01/2002
6	Carcinogenesis 01/2019 - 10/2007
6	Chromosomal Instability (Chromosome Stability) 09/2015 - 01/2002
5	Breast Neoplasms (Breast Cancer) 08/2021 - 02/2011
5	Severe Combined Immunodeficiency (Bare Lymphocyte Syndrome) 11/2011 - 07/2005
4	Chromosome Aberrations (Chromosome Abnormalities) 01/2024 - 09/2012
4	B-Cell Lymphoma (Lymphoma, B Cell) 01/2023 - 04/2002
4	Bites and Stings (Sting) 01/2022 - 06/2020
4	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 11/2021 - 07/2006

Drug/Important Bio-Agent (IBA)

152	Bortezomib (Velcade)FDA Link 03/2024 - 05/2002
77	Proteasome InhibitorsIBA 03/2024 - 05/2002
71	Dexamethasone (Maxidex)FDA LinkGeneric 02/2024 - 02/2002
67	Lenalidomide (CC 5013)FDA Link 11/2023 - 11/2002
43	Proteins (Proteins, Gene)FDA Link 03/2024 - 03/2002
40	Thalidomide (Thalomid)FDA Link 01/2021 - 04/2002
37	Proteasome Endopeptidase Complex (Proteasome)IBA 01/2023 - 10/2002
28	Monoclonal AntibodiesIBA 02/2024 - 04/2003
28	Interleukin-6 (Interleukin 6)IBA 10/2021 - 01/2002
27	Immunomodulating AgentsIBA 11/2021 - 05/2002
26	CytokinesIBA 03/2024 - 01/2002
24	Melphalan (Alkeran)FDA LinkGeneric 05/2024 - 07/2002
24	AntigensIBA 04/2024 - 04/2003
23	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2016 - 02/2002
20	bis(3- bis(4- chlorophenyl)methyl- 4- dimethylaminophenyl)amineIBA 12/2023 - 05/2005
18	NF-kappa B (NF-kB)IBA 07/2013 - 05/2002
16	pomalidomideIBA 02/2024 - 09/2006
14	DNA (Deoxyribonucleic Acid)IBA 01/2020 - 03/2003
13	Histone Deacetylase InhibitorsIBA 04/2024 - 04/2003
12	Biomarkers (Surrogate Marker)IBA 11/2023 - 10/2007
11	Peptides (Polypeptides)IBA 01/2021 - 06/2003
11	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2021 - 03/2002
10	Histone Deacetylases (Histone Deacetylase)IBA 04/2024 - 10/2003
10	B-Cell Maturation AntigenIBA 03/2024 - 07/2006
10	Immunoglobulins (Immunoglobulin)IBA 12/2023 - 03/2002
10	UbiquitinIBA 01/2023 - 08/2006
10	Immunoconjugates (Immunoconjugate)IBA 12/2021 - 07/2004
10	perifosineIBA 07/2020 - 05/2006
10	MicroRNAs (MicroRNA)IBA 01/2020 - 04/2009
10	EnzymesIBA 01/2018 - 10/2003
10	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 11/2014 - 01/2003
9	Telomerase (Telomerase Reverse Transcriptase)IBA 03/2024 - 01/2002
9	Heat-Shock Proteins (Heat-Shock Protein)IBA 02/2024 - 10/2002
9	Phosphotransferases (Kinase)IBA 12/2017 - 03/2004
8	daratumumabIBA 02/2024 - 02/2011
8	Alkylating AgentsIBA 01/2023 - 08/2006
8	Immunoglobulin M (IgM)IBA 01/2023 - 04/2003
8	elotuzumabIBA 12/2021 - 08/2008
8	LigandsIBA 10/2021 - 03/2002
8	Vorinostat FDA Link 01/2016 - 04/2003
8	tanespimycin (17AAG)IBA 12/2011 - 02/2006
8	Insulin-Like Growth Factor I (IGF-1)IBA 01/2009 - 08/2002
7	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 03/2024 - 01/2003
7	Histones (Histone)IBA 01/2023 - 05/2009
7	carfilzomibIBA 10/2020 - 07/2013
7	Prednisone (Sone)FDA LinkGeneric 01/2018 - 08/2005
7	Immunoglobulin G (IgG)IBA 07/2014 - 07/2005
7	Rituximab (Mabthera)FDA Link 09/2010 - 01/2005
7	Antineoplastic Agents (Antineoplastics)IBA 05/2010 - 09/2002
6	isatuximabIBA 02/2024 - 08/2017
6	Messenger RNA (mRNA)IBA 01/2021 - 04/2002
6	AntibodiesIBA 11/2019 - 03/2002
6	marizomibIBA 09/2016 - 11/2005
6	PanobinostatIBA 10/2013 - 11/2011
6	CaspasesIBA 06/2013 - 11/2003
6	GlucocorticoidsIBA 07/2012 - 01/2005
6	Cytotoxins (Cytolysins)IBA 04/2009 - 07/2004
6	InterleukinsIBA 01/2009 - 05/2004
6	Insulin-Like PeptidesIBA 01/2009 - 01/2002
5	Insulin (Novolin)FDA Link 03/2024 - 08/2002
5	OligonucleotidesIBA 03/2024 - 02/2002
5	Complement System Proteins (Complement)IBA 01/2020 - 04/2003
5	ixazomibIBA 01/2018 - 08/2011
5	Zoledronic Acid (Zometa)FDA Link 03/2016 - 02/2009
5	Sirolimus (Rapamycin)FDA Link 11/2014 - 12/2004
5	Interleukin-6 Receptors (Interleukin 6 Receptor)IBA 12/2012 - 06/2005
5	enzastaurinIBA 07/2011 - 02/2007
5	Protein Kinase CIBA 02/2009 - 05/2004
4	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 01/2024 - 09/2012
4	Cyclin-Dependent Kinases (cdk Proteins)IBA 01/2023 - 06/2003
4	Chimeric Antigen ReceptorsIBA 12/2021 - 11/2019

Therapy/Procedure

207	Therapeutics 01/2024 - 01/2002
28	Drug Therapy (Chemotherapy) 03/2024 - 01/2002
22	Stem Cell Transplantation 01/2023 - 01/2002
22	Immunotherapy 01/2022 - 06/2003
11	Transplantation 01/2022 - 01/2002
4	Precision Medicine 12/2021 - 10/2015